Session II: Practical considerations, standard of care and emerging biomarkers
Debate: Cisplatin Ineligible Patient Underwent Radical Cystectomy with pT3N1 Bladder Urothelial Carcinoma with Extensive Squamous Cell Features. Adjuvant Nivolumab? Yes or No - NO